Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.72 USD | -0.41% |
|
-3.47% | +288.82% |
06-24 | Janux Therapeutics, Inc.(NasdaqGM:JANX) added to S&P Biotechnology Select Industry Index | CI |
06-06 | Janux Therapeutics Insider Sold Shares Worth $45,043,975, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+288.82% | 2.17B | |
+16.59% | 45.51B | |
-9.89% | 38.52B | |
+38.08% | 38.13B | |
+27.12% | 30.74B | |
-8.64% | 26.03B | |
+11.81% | 25.92B | |
+45.08% | 14.13B | |
+32.85% | 12.73B | |
-7.19% | 11.29B |
- Stock Market
- Equities
- JANX Stock
- News Janux Therapeutics, Inc.
- Janux Therapeutics : Evercore ISI Starts Janux Therapeutics at Outperform With $35 Price Target